Orlaskin Salicylic Acid Acne Treatment Pads Paste
NDC Package 87582-006-01
Package Information
Orlaskin Salicylic Acid Acne Treatment Pads (salicylic acid) pastes is directions cleanse the skin thoroughly before applying this product wipe the entire affected area with one pad because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor if bothersome dryness or peeling occurs, reduce application to once a day or every other day Other information Keep tightly closed store in a cool & dry place. This formulation utilizes a paste delivery system. Marketed by Guangzhou Yapheon Health Industry Co., Ltd., this product is identified by NDC 87582-006 and is authorized under FDA application M006.
Identification & Billing
- RxCUI: 797892 - salicylic acid 2 % Medicated Pad
- RxCUI: 797892 - salicylic acid 20 MG/ML Medicated Pad
- RxCUI: 797892 - salicylic acid 2 % Topical Swab
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 87582 - Guangzhou Yapheon Health Industry Co., Ltd.
- 87582-006 - Orlaskin Salicylic Acid Acne Treatment Pads
- 87582-006-01 - 80 PATCH in 1 BOX / 1.25 g in 1 PATCH
- 87582-006 - Orlaskin Salicylic Acid Acne Treatment Pads
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 87582-006-01 identifies a specific commercial package of 80 patch in 1 box / 1.25 g in 1 patch of Orlaskin Salicylic Acid Acne Treatment Pads, a human over the counter drug labeled by Guangzhou Yapheon Health Industry Co., Ltd.. This paste is formulated for topical use and contains salicylic acid as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Guangzhou Yapheon Health Industry Co., Ltd. on June 27, 2026. The current certification is valid through December 31, 2027.
How is this Guangzhou Yapheon Health Industry Co., Ltd. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 87582000601. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.